You just read:

Lancet Neurology Publishes Pivotal Phase III Data Supporting Zonegran® (Zonisamide) as a Once-Daily Monotherapy for Newly Diagnosed Partial Onset Epilepsy Patients

News provided by

Eisai Europe Limited

27 Jun, 2012, 00:01 BST